These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 19843396)

  • 41. Transmission assessment surveys in the Global Programme to Eliminate Lymphatic Filariasis: WHO position statement.
    Wkly Epidemiol Rec; 2012 Nov; 87(48):478-82. PubMed ID: 23213667
    [No Abstract]   [Full Text] [Related]  

  • 42. Lymphatic filariasis elimination programme in India: progress and challenges.
    Ramaiah KD
    Trends Parasitol; 2009 Jan; 25(1):7-8. PubMed ID: 19008150
    [No Abstract]   [Full Text] [Related]  

  • 43. Efficacy of ivermectin and albendazole combination in suppressing transmission of lymphatic filariasis following mass administration in Tanzania: a prospective cohort study.
    Fimbo AM; Mnkugwe RH; Mlugu EM; Kunambi PP; Malishee A; Minzi OMS; Kamuhabwa AAR; Aklillu E
    Infect Dis Poverty; 2024 Jun; 13(1):44. PubMed ID: 38867265
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lymphatic filariasis.
    Wkly Epidemiol Rec; 2003 May; 78(20):171-9. PubMed ID: 12808788
    [No Abstract]   [Full Text] [Related]  

  • 45. Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa.
    Fischer PU; King CL; Jacobson JA; Weil GJ
    PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005163. PubMed ID: 28056015
    [No Abstract]   [Full Text] [Related]  

  • 46. The Importance of Partnership in the Rollout of Triple-Drug Therapy to Eliminate Lymphatic Filariasis in the Pacific.
    Rainima-Qaniuci M; Lepaitai HB; Bhagirov R; Padmasiri E; Naseri T; Thomsen R; Won KY; Brant TA; Dodd E; Nua MT; Utu F; Tufa A; Chutaro E; Camacho J; Suiaunoa-Scanlan L; Thean LJ; Mani J; Hardy M; Samuela J; Romani L; Kaldor J; Steer AC; Faktaufon D; Bechu V; Naqio F; Sosene V; Sekihara M; Otaki J; Buhagiar TS; Yajima A
    Am J Trop Med Hyg; 2022 May; 106(5_Suppl):39-47. PubMed ID: 35292579
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Modelling the epidemiology, transmission and control of lymphatic filariasis.
    Das PK; Subramanian S
    Ann Trop Med Parasitol; 2002 Dec; 96 Suppl 2():S153-64. PubMed ID: 12625928
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Setting the stage for a Global Programme to Eliminate Lymphatic Filariasis: the first 125 years (1875-2000).
    Ottesen EA; Horton J
    Int Health; 2020 Dec; 13(Suppl 1):S3-S9. PubMed ID: 33349877
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Decline in lymphatic filariasis transmission with annual mass drug administration using DEC with and without albendazole over a 10year period in India.
    Sunish IP; Kalimuthu M; Rajendran R; Munirathinam A; Ashok Kumar V; Nagaraj J; Tyagi BK
    Parasitol Int; 2015 Feb; 64(1):1-4. PubMed ID: 25205435
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Country Reports on Practical Aspects of Conducting Large-Scale Community Studies of the Tolerability of Mass Drug Administration with Ivermectin/Diethylcarbamazine/Albendazole for Lymphatic Filariasis.
    Jambulingam P; Subramanian S; Krishnamoorthy K; Supali T; Fischer P; Dubray C; Fayette C; Lemoine JF; Laman M; King C; Samuela J; Hardy M; Weil GJ
    Am J Trop Med Hyg; 2022 May; 106(5_Suppl):18-25. PubMed ID: 35292582
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Elimination of lymphatic filariasis as a public health problem.
    Cox FE
    Parasitol Today; 2000 Apr; 16(4):135. PubMed ID: 10725894
    [No Abstract]   [Full Text] [Related]  

  • 52. Determinants of parasite drug resistance in human lymphatic filariasis.
    Cobo F
    Rev Esp Quimioter; 2016 Dec; 29(6):288-295. PubMed ID: 27858056
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Individual Efficacy and Community Impact of Ivermectin, Diethylcarbamazine, and Albendazole Mass Drug Administration for Lymphatic Filariasis Control in Fiji: A Cluster Randomized Trial.
    Hardy M; Samuela J; Kama M; Tuicakau M; Romani L; Whitfeld MJ; King CL; Weil GJ; Grobler AC; Robinson LJ; Kaldor JM; Steer AC
    Clin Infect Dis; 2021 Sep; 73(6):994-1002. PubMed ID: 33728462
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Progress towards eliminating lymphatic filariasis in Zanzibar: a model programme.
    Mohammed KA; Molyneux DH; Albonico M; Rio F
    Trends Parasitol; 2006 Jul; 22(7):340-4. PubMed ID: 16713740
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mass drug treatment for lymphatic filariasis and onchocerciasis.
    Molyneux DH; Bradley M; Hoerauf A; Kyelem D; Taylor MJ
    Trends Parasitol; 2003 Nov; 19(11):516-22. PubMed ID: 14580963
    [No Abstract]   [Full Text] [Related]  

  • 56. Introduction of Triple-Drug Therapy for Accelerating Lymphatic Filariasis Elimination in India: Lessons Learned.
    Tripathi B; Roy N; Dhingra N
    Am J Trop Med Hyg; 2022 May; 106(5_Suppl):29-38. PubMed ID: 35292580
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical characteristics of post-treatment reactions to ivermectin/albendazole for Wuchereria bancrofti in a region co-endemic for Mansonella perstans.
    Keiser PB; Coulibaly YI; Keita F; Traore D; Diallo A; Diallo DA; Semnani RT; Doumbo OK; Traore SF; Klion AD; Nutman TB
    Am J Trop Med Hyg; 2003 Sep; 69(3):331-5. PubMed ID: 14628953
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of 10 years of diethylcarbamazine and ivermectin mass administration on infection and transmission of lymphatic filariasis.
    Ramaiah KD; Das PK; Vanamail P; Pani SP
    Trans R Soc Trop Med Hyg; 2007 Jun; 101(6):555-63. PubMed ID: 17374389
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Strategies and tools for the control/elimination of lymphatic filariasis.
    Ottesen EA; Duke BO; Karam M; Behbehani K
    Bull World Health Organ; 1997; 75(6):491-503. PubMed ID: 9509621
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Trial of a Triple-Drug Treatment for Lymphatic Filariasis.
    King CL; Suamani J; Sanuku N; Cheng YC; Satofan S; Mancuso B; Goss CW; Robinson LJ; Siba PM; Weil GJ; Kazura JW
    N Engl J Med; 2018 Nov; 379(19):1801-1810. PubMed ID: 30403937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.